首页> 外国专利> Diagnosing infection, SIRS or sepsis using RT-PCR and biomarkers

Diagnosing infection, SIRS or sepsis using RT-PCR and biomarkers

机译:使用RT-PCR和生物标记物诊断感染,SIRS或败血症

摘要

A method for screening a biological sample to detect early stages of infection, SIRS or sepsis comprising the steps of detecting expression of at least one biomarker from a first set and one from a second set of informative biomarkers by RT-PCR; analysing the results of detection; classifying said sample according to the likelihood and/or timing of the development of overt infection. The first set of biomarkers consists of CD40, CD5, CD79A, CRX, CTNND1, CX3CL1, ENTPD2, ENTPD5, EPHA8, GPR44, HMMR, IL8, MAP1A, MAPK7, MEF2D, ODF1, SAA3P, SLC6A9, SPN, TDGF1, TSC22D1 and HDAC5, the second set consists of CD178, MCP-1, TNF-alpha, IL- 1beta, IL-6, IL-10, INF-alpha and INF-gamma. A multilayered perceptron neural network analysis may be used for high accuracy prediction. A diagnostic means may be prepared from the method.
机译:一种用于筛选生物样品以检测感染,SIRS或败血症的早期阶段的方法,该方法包括以下步骤:通过RT-PCR从第一组信息性生物标志物中检测至少一种生物标志物,从第二组生物信息性标志中检测至少一种生物标志物的表达。分析检测结果;根据明显感染发生的可能性和/或时机对样品进行分类。第一组生物标记包括CD40,CD5,CD79A,CRX,CTNND1,CX3CL1,ENTPD2,ENTPD5,EPHA8,GPR44,HMMR,IL8,MAP1A,MAPK7,MEF2D,ODF1,SAA3P,SLC6A9,SPN,TDDAC1,HSC ,第二组由CD178,MCP-1,TNF-α,IL-1β,IL-6,IL-10,INF-α和INF-γ组成。多层感知器神经网络分析可用于高精度预测。可以从该方法制备诊断手段。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号